SCHEMBL25720201

SCHEMBL25720201

COc1ccccc1NC(=O)c1c(OC)c2ccccc2n(CC(C)C)c1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.60
HSD17B10 Q99714 2/20 0.60
MEN1 O00255 7/20 0.57
KMT2A Q03164 7/20 0.57
KDM4E B2RXH2 6/20 0.57
ALDH1A1 P00352 5/20 0.57
HTT P42858 4/20 0.57
LMNA P02545 3/20 0.57
USP2 O75604 3/20 0.57
TSHR P16473 2/20 0.57
GAA P10253 1/20 0.57
HSP90AA1 P07900 1/20 0.53
ALOX15 P16050 1/20 0.53
MAPT P10636 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
SMN1; SMN2 Q16637 4/20 0.48
NPSR1 Q6W5P4 2/20 0.48
S1PR2 O95136 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24054540 0.91 HPGD (0.73) HPGDHSD17B10MEN1KMT2AKDM4E
SCHEMBL25720177 0.89 MEN1 (0.57) HPGDHSD17B10MEN1KMT2AKDM4E
SCHEMBL25720195 0.85 HSP90AA1 (0.53) HPGDHSD17B10MEN1KMT2AKDM4E
SCHEMBL25720792 0.84 HSP90AA1 (0.59) HPGDHSD17B10MEN1KMT2AKDM4E
SCHEMBL25720827 0.83 KMT2A (0.51) HPGDHSD17B10MEN1KMT2AKDM4E
SCHEMBL25720179 0.82 HSP90AA1 (0.77) HPGDHSD17B10MEN1KMT2AKDM4E
SCHEMBL25720176 0.81 HSP90AA1 (0.63) HPGDHSD17B10MEN1KMT2AKDM4E
SCHEMBL25720873 0.79 MEN1 (0.47) HPGDHSD17B10MEN1KMT2AKDM4E
SCHEMBL25720189 0.79 HSP90AA1 (0.49) MEN1KMT2AKDM4EALDH1A1HTT
SCHEMBL25720137 0.78 SHMT2 (0.52) HPGDHSD17B10MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203003-A1 Notch Inhibitors and Uses Thereof STEMSYNERGY THERAPEUTICS, INC. 2023-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203003-A1 Notch Inhibitors and Uses Thereof NOTCH1, NOTCH2, NOTCH4 HPGD 2805/4885HSD17B10 2619/4885MEN1 576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.